22q11.2 deletion syndrome (22q11.2DS) is a neurogenetic condition associated with increased risk for schizophrenia. No study do date has explored how positive and negative symptoms of psychosis are distributed among individual patients with 22q11.2DS and if distinct patterns of symptoms can be identified. Negative symptoms being more frequent than positive symptoms in 22q11.2DS, we expected that a high number of patients would display predominant negative symptoms (PNS), whereas predominant positive symptoms would be less frequently reported. The present study aims at investigating the cognitive deficits and functional outcome associated with distinct patterns of psychotic symptoms in 22q11.2DS. 63 adolescents and young adults with 22q11.2D...
Adults with 22q11.2 Deletion syndrome (22q11DS) have increased prevalence of schizophrenia features....
ImportancePatients with 22q11.2 deletion syndrome (22q11DS) have an elevated (25%) risk of developin...
22q11.2 Deletion Syndrome (22q11.2DS) is associated with high risk of psychiatric disorders and cogn...
22q11.2 deletion syndrome (22q11.2DS) is a neurogenetic condition associated with increased risk for...
BACKGROUND: The 22q11.2 deletion syndrome (22q11DS) is one of the highest known risk factors for sch...
22q11.2 deletion syndrome (22q11.2DS) is a neurogenetic condition associated with an increased risk ...
22q11.2 deletion syndrome (22q11DS) is associated with increased risk for schizophrenia. Better iden...
Approximately 30% of individuals with 22q11.2 Deletion Syndrome (22q11DS) develop schizophrenia duri...
Objective: Genetic syndromes related to psychosis have become increasingly important for exploring t...
Current research in schizophrenia suggests that negative symptoms cannot be considered a unitary con...
Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk for developing schizophre...
Importance: Patients with 22q11.2 deletion syndrome (22q11DS) have an elevated (25%) risk of develop...
IMPORTANCE Patients with 22q11.2 deletion syndrome (22q11DS) have an elevated (25%) risk of developi...
Adults with 22q11.2 Deletion syndrome (22q11DS) have increased prevalence of schizophrenia features....
ImportancePatients with 22q11.2 deletion syndrome (22q11DS) have an elevated (25%) risk of developin...
22q11.2 Deletion Syndrome (22q11.2DS) is associated with high risk of psychiatric disorders and cogn...
22q11.2 deletion syndrome (22q11.2DS) is a neurogenetic condition associated with increased risk for...
BACKGROUND: The 22q11.2 deletion syndrome (22q11DS) is one of the highest known risk factors for sch...
22q11.2 deletion syndrome (22q11.2DS) is a neurogenetic condition associated with an increased risk ...
22q11.2 deletion syndrome (22q11DS) is associated with increased risk for schizophrenia. Better iden...
Approximately 30% of individuals with 22q11.2 Deletion Syndrome (22q11DS) develop schizophrenia duri...
Objective: Genetic syndromes related to psychosis have become increasingly important for exploring t...
Current research in schizophrenia suggests that negative symptoms cannot be considered a unitary con...
Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk for developing schizophre...
Importance: Patients with 22q11.2 deletion syndrome (22q11DS) have an elevated (25%) risk of develop...
IMPORTANCE Patients with 22q11.2 deletion syndrome (22q11DS) have an elevated (25%) risk of developi...
Adults with 22q11.2 Deletion syndrome (22q11DS) have increased prevalence of schizophrenia features....
ImportancePatients with 22q11.2 deletion syndrome (22q11DS) have an elevated (25%) risk of developin...
22q11.2 Deletion Syndrome (22q11.2DS) is associated with high risk of psychiatric disorders and cogn...